DPP-4 inhibitors improve liver dysfunction in type 2 diabetes mellitus
Their genetic background makes them highly suited for exploring core aspects of AD pathology, such as amyloid-beta (A) aggregation, tau hyperphosphorylation, neuroinflammation, synaptic dysfunction, and cognitive decline
Although early, these findings highlight how therapies developed for cardiometabolic disease may intersect with hallmarks such as telomere attrition
While the results of this preliminary study conducted using a small sample size is not sufficient to generalize these benefits, our results emphasize the potential of this naturally occurring combination to be developed into a safe, effective therapeutic strategy to manage ADHD
Artificial enzyme catalyzed cascade reactions: Antitumor immunotherapy reinforced by NIR-II light
doi: 10.1111/J.1439-0523.2006.01247.X 302 XiaoF.WangX.LiuS